Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tetrazole hybrids with potential anticancer activity
Jingyu Zhang, Su Wang, Yanyan Ba, et al.
European Journal of Medicinal Chemistry (2019) Vol. 178, pp. 341-351
Closed Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships
Zhi Xu, Shijia Zhao, Yi Liu
European Journal of Medicinal Chemistry (2019) Vol. 183, pp. 111700-111700
Closed Access | Times Cited: 411
Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships
Ruo Wang, Huahong Chen, Weitao Yan, et al.
European Journal of Medicinal Chemistry (2020) Vol. 190, pp. 112109-112109
Closed Access | Times Cited: 156
Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure‐activity relationship
Feng Gao, Gang Huang, Jiaqi Xiao
Medicinal Research Reviews (2020) Vol. 40, Iss. 5, pp. 2049-2084
Closed Access | Times Cited: 102
Recent advances in isatin hybrids as potential anticancer agents
Zhen Ding, Minfeng Zhou, Cheng Zeng
Archiv der Pharmazie (2020) Vol. 353, Iss. 3
Closed Access | Times Cited: 96
Tetrazoles as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies
Neha Dhiman, Kamalpreet Kaur, Vikas Jaitak
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 15, pp. 115599-115599
Closed Access | Times Cited: 93
1,3,4-Oxadiazole-containing hybrids as potential anticancer agents: Recent developments, mechanism of action and structure-activity relationships
Swarnagowri Nayak, Santosh L. Gaonkar, Ebraheem Abdu Musad, et al.
Journal of Saudi Chemical Society (2021) Vol. 25, Iss. 8, pp. 101284-101284
Open Access | Times Cited: 71
Use of tetrazoles in catalysis and energetic applications: Recent developments
Mahmoud Nasrollahzadeh, Zahra Nezafat, Nayyereh Sadat Soheili Bidgoli, et al.
Molecular Catalysis (2021) Vol. 513, pp. 111788-111788
Closed Access | Times Cited: 55
Novel 1,2,3-Triazole-Coumarin Hybrid Glycosides and Their Tetrazolyl Analogues: Design, Anticancer Evaluation and Molecular Docking Targeting EGFR, VEGFR-2 and CDK-2
Wael A. El‐Sayed, Fahad M. Alminderej, Marwa M. Mounier, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2047-2047
Open Access | Times Cited: 40
Anticancer evaluation and molecular docking of new pyridopyrazolo-triazine and pyridopyrazolo-triazole derivatives
Mohamed R. Elmorsy, Ehab Abdel‐Latif, Hatem E. Gaffer, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Green Methodologies for Tetrazole Synthesis from Different Starting Materials: A Recent Update
Shivangi Jaiswal, Jaya Dwivedi, Dharma Kishore, et al.
Current Organic Chemistry (2024) Vol. 28, Iss. 2, pp. 134-160
Closed Access | Times Cited: 6
Isatin–azole hybrids and their anticancer activities
Yani Hou, Congshan Shang, Hui Wang, et al.
Archiv der Pharmazie (2019) Vol. 353, Iss. 1
Closed Access | Times Cited: 68
Bioisosteres in Drug Discovery: Focus on Tetrazole
Yulin Zou, Li Liu, Junxiong Liu, et al.
Future Medicinal Chemistry (2019) Vol. 12, Iss. 2, pp. 91-93
Open Access | Times Cited: 67
2-Aminothiazole: A privileged scaffold for the discovery of anti-cancer agents
Yichao Wan, Jiabing Long, Han Gao, et al.
European Journal of Medicinal Chemistry (2020) Vol. 210, pp. 112953-112953
Closed Access | Times Cited: 56
Isatin dimers and their biological activities
Yazhou Zhang, Hongzhi Du, Hai‐Lin Liu, et al.
Archiv der Pharmazie (2020) Vol. 353, Iss. 3
Closed Access | Times Cited: 53
Recent advances in antifungal drug development targeting lanosterol 14α‐demethylase (CYP51): A comprehensive review with structural and molecular insights
Atamjit Singh, Karanvir Singh, Aman Sharma, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 3, pp. 606-639
Closed Access | Times Cited: 14
Tetrazole derivatives in the management of neurological disorders: Recent advances on synthesis and pharmacological aspects
Shivangi Jaiswal, Kanika Verma, Jaya Dwivedi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116388-116388
Closed Access | Times Cited: 5
Tetrazoles: A multi-potent motif in drug design
Ye Yuan, Muzi Li, Vasso Apostolopoulos, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116870-116870
Open Access | Times Cited: 4
Novel adamantane-pyrazole and hydrazone hybridized: Design, synthesis, cytotoxic evaluation, SAR study and molecular docking simulation as carbonic anhydrase inhibitors
Mohammed M. S. Wassel, Ahmed Ragab, Gameel A. M. El‐Hag Ali, et al.
Journal of Molecular Structure (2020) Vol. 1223, pp. 128966-128966
Closed Access | Times Cited: 45
Recent Development of 1,2,4-triazole-containing Compounds as Anticancer Agents
Xiaoyue Wen, Yong-qin Zhou, Junhao Zeng, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 16, pp. 1441-1460
Closed Access | Times Cited: 41
Recent Advances on Stimuli-Responsive Combination Therapy against Multidrug-Resistant Bacteria and Biofilm
Antara Sikder, Amrita Chaudhuri, Saugat Mondal, et al.
ACS Applied Bio Materials (2021) Vol. 4, Iss. 6, pp. 4667-4683
Closed Access | Times Cited: 38
Platinum and palladium complexes with tetrazole ligands: Synthesis, structure and applications
Mahmoud Nasrollahzadeh, Mohaddeseh Sajjadi, Hossein Ghafuri, et al.
Coordination Chemistry Reviews (2021) Vol. 446, pp. 214132-214132
Closed Access | Times Cited: 38
Novel pyrazole-based COX-2 inhibitors as potential anticancer agents: Design, synthesis, cytotoxic effect against resistant cancer cells, cell cycle arrest, apoptosis induction and dual EGFR/Topo-1 inhibition
Peter A. Halim, Souty M.Z. Sharkawi, Madlen B. Labib
Bioorganic Chemistry (2022) Vol. 131, pp. 106273-106273
Closed Access | Times Cited: 24
Tetrazole: A privileged scaffold for the discovery of anticancer agents
Anil Verma, Balwinder Kaur, Sneha Venugopal, et al.
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 3, pp. 419-442
Closed Access | Times Cited: 23
Synthesis of 4-Tetrazolyl-Substituted 3,4-Dihydroquinazoline Derivatives with Anticancer Activity via a One-Pot Sequential Ugi-Azide/Palladium-Catalyzed Azide-Isocyanide Cross-Coupling/Cyclization Reaction
Jun Xiong, Huiting He, He‐Yu Yang, et al.
The Journal of Organic Chemistry (2022) Vol. 87, Iss. 15, pp. 9488-9496
Closed Access | Times Cited: 21
Synthesis, Antimicrobial, and DNA-Binding Evaluation of Novel Schiff Bases Containing Tetrazole Moiety And Their Ni(II) and Pt(II) Complexes
M. Ulular, Nurşen Sarı, Fu‐She Han, et al.
Pharmaceutical Chemistry Journal (2024) Vol. 57, Iss. 10, pp. 1609-1620
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top